125 related articles for article (PubMed ID: 18602017)
1. Emerging treatments for thrombocytopenia: increasing platelet production.
Peeters K; Stassen JM; Collen D; Van Geet C; Freson K
Drug Discov Today; 2008 Sep; 13(17-18):798-806. PubMed ID: 18602017
[TBL] [Abstract][Full Text] [Related]
2. Clinical findings with the first generation of thrombopoietic agents.
Vadhan-Raj S
Semin Hematol; 2010 Jul; 47(3):249-57. PubMed ID: 20620436
[TBL] [Abstract][Full Text] [Related]
3. Thrombopoietin mimetic agents in the management of immune thrombocytopenic purpura.
Newland A
Semin Hematol; 2007 Oct; 44(4 Suppl 5):S35-45. PubMed ID: 18096471
[TBL] [Abstract][Full Text] [Related]
4. The effect of a novel, small non-peptidyl molecule butyzamide on human thrombopoietin receptor and megakaryopoiesis.
Nogami W; Yoshida H; Koizumi K; Yamada H; Abe K; Arimura A; Yamane N; Takahashi K; Yamane A; Oda A; Tanaka Y; Takemoto H; Ohnishi Y; Ikeda Y; Miyakawa Y
Haematologica; 2008 Oct; 93(10):1495-504. PubMed ID: 18728031
[TBL] [Abstract][Full Text] [Related]
5. Thrombopoietic effect of VPAC1 inhibition during megakaryopoiesis.
Peeters K; Loyen S; Van Kerckhoven S; Stoffels K; Hoylaerts MF; Van Geet C; Freson K
Br J Haematol; 2010 Oct; 151(1):54-61. PubMed ID: 20735399
[TBL] [Abstract][Full Text] [Related]
6. Challenges in the development of platelet growth factors: low expectations for low counts.
Brown JR; Demetri GD
Curr Hematol Rep; 2002 Nov; 1(2):110-8. PubMed ID: 12901132
[TBL] [Abstract][Full Text] [Related]
7. Megakaryocyte development and platelet production.
Deutsch VR; Tomer A
Br J Haematol; 2006 Sep; 134(5):453-66. PubMed ID: 16856888
[TBL] [Abstract][Full Text] [Related]
8. Review article: thrombocytopenia in chronic liver disease and pharmacologic treatment options.
Giannini EG
Aliment Pharmacol Ther; 2006 Apr; 23(8):1055-65. PubMed ID: 16611265
[TBL] [Abstract][Full Text] [Related]
9. Cytokines for the treatment of thrombocytopenia.
Ciurea SO; Hoffman R
Semin Hematol; 2007 Jul; 44(3):166-82. PubMed ID: 17631181
[TBL] [Abstract][Full Text] [Related]
10. Early Australian clinical studies with pegylated recombinant human megakaryocyte growth and development factor.
Basser RL
Stem Cells; 1998; 16 Suppl 2():225-9. PubMed ID: 11012194
[TBL] [Abstract][Full Text] [Related]
11. PEG-rHuMGDF ameliorates thrombocytopenia in carboplatin-treated rats without inducing myelofibrosis.
Ide Y; Harada K; Imai A; Yanagida M
Int J Hematol; 1999 Aug; 70(2):91-6. PubMed ID: 10497847
[TBL] [Abstract][Full Text] [Related]
12. Characterization and transplantation of induced megakaryocytes from hematopoietic stem cells for rapid platelet recovery by a two-step serum-free procedure.
Chen TW; Hwang SM; Chu IM; Hsu SC; Hsieh TB; Yao CL
Exp Hematol; 2009 Nov; 37(11):1330-1339.e5. PubMed ID: 19664680
[TBL] [Abstract][Full Text] [Related]
13. Treatment of lupus-induced thrombocytopenia with recombinant human interleukin-11.
Feinglass S; Deodhar A
Arthritis Rheum; 2001 Jan; 44(1):170-5. PubMed ID: 11212156
[TBL] [Abstract][Full Text] [Related]
14. 2-O, 3-O desulfated heparin mitigates murine chemotherapy- and radiation-induced thrombocytopenia.
Tkaczynski E; Arulselvan A; Tkaczynski J; Avery S; Xiao L; Torok-Storb B; Abrams K; Rao NV; Johnson G; Kennedy TP; Poncz M; Lambert MP
Blood Adv; 2018 Apr; 2(7):754-761. PubMed ID: 29599195
[TBL] [Abstract][Full Text] [Related]
15. Overview of the safety and biologic effects of PEG-rHuMGDF in clinical trials.
Sheridan W; Menchaca D
Stem Cells; 1998; 16 Suppl 2():193-8. PubMed ID: 11012191
[TBL] [Abstract][Full Text] [Related]
16. Oprelvekin: an alternative treatment for thrombocytopenia.
Rust DM; Wood LS; Battiato LA
Clin J Oncol Nurs; 1999 Apr; 3(2):57-62. PubMed ID: 10633612
[TBL] [Abstract][Full Text] [Related]
17. Biologic aspects of thrombopoietins and the development of therapeutic agents.
Solberg LA
Curr Hematol Rep; 2005 Nov; 4(6):423-8. PubMed ID: 16232377
[TBL] [Abstract][Full Text] [Related]
18. Thrombopoietic stimulating activity of rhTyrRS (Y341A).
Jinchao Y; Yanling Z; Xu W; Bing Z; Yuhao Y; Weiran Z; Shaoyang S; Liyun M; Yun S; Ling Z; Min Y; Wei M
Sci Rep; 2017 Sep; 7(1):12184. PubMed ID: 28939876
[TBL] [Abstract][Full Text] [Related]
19. Acute thrombocytopenia after liver transplant: role of platelet activation, thrombopoietin deficiency and response to high dose intravenous IgG treatment.
Nascimbene A; Iannacone M; Brando B; De Gasperi A
J Hepatol; 2007 Nov; 47(5):651-7. PubMed ID: 17716776
[TBL] [Abstract][Full Text] [Related]
20. Thrombopoietic factors in chronic bone marrow failure states: the platelet problem revisited.
Kurzrock R
Clin Cancer Res; 2005 Feb; 11(4):1361-7. PubMed ID: 15746033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
